Provided by Tiger Trade Technology Pte. Ltd.

Organon & Co

13.65
+0.01000.07%
Post-market: 13.64-0.0100-0.07%16:36 EDT
Volume:1.25M
Turnover:17.08M
Market Cap:3.58B
PE:17.22
High:13.67
Open:13.64
Low:13.64
Close:13.64
52wk High:13.79
52wk Low:5.69
Shares:262.60M
Float Shares:243.00M
Volume Ratio:0.39
T/O Rate:0.52%
Dividend:0.08
Dividend Rate:0.59%
EPS(TTM):0.7929
EPS(LYR):0.7200
ROE:24.04%
ROA:5.67%
PB:3.56
PE(LYR):18.96

Loading ...

Organon says FDA approves expanded TOFIDENCE use in CAR-T cytokine release syndrome

Reuters
·
Jun 10

Organon & Co - Tofidence Injection Available in 80 Mg, 200 Mg, 400 Mg Single-Dose Vials

THOMSON REUTERS
·
Jun 10

Organon Secures US Food and Drug Administration Approval Expanding Indications for Tofidence® (Tocilizumab-Bavi) in Cytokine Release Syndrome (Crs) and Pediatric Covid-19

THOMSON REUTERS
·
Jun 10

Market Chatter: Organon Acquisition May Receive $1 Billion Commitment From State Bank of India

MT Newswires Live
·
Jun 09

India's Sun Pharma posts profit beat on specialty drug demand, shares slide on cost pressures

Reuters
·
May 22

Hanmi Pharm Co Ltd - Pharmaceutical Signs Supply Agreement With Organon for Malaysia and Philippines

THOMSON REUTERS
·
May 21

Health Rounds: Widely used asthma drug may improve performance of cancer immunotherapies

Reuters
·
May 20

Assessing Organon (OGN) Valuation After A Sharp Recent Share Price Move

Simply Wall St.
·
May 08

Organon SVP, Corporate Controller Lynette Holzbaur acquires shares worth $353,080.54

Reuters
·
May 07

Is It Time To Reassess Organon (OGN) After Its Sharp Recent Share Price Surge?

Simply Wall St.
·
May 06

MEDIA-Sun Pharma explores funding mix for $12 billion Organon deal - Bloomberg News

Reuters
·
May 06

INDIA FILE-Homegrown companies are making bolder global bets

Reuters
·
May 05

Earning Preview: Organon & Co Q1 revenue is expected to decrease by 1.58%, and institutional views are neutral to cautious

Earnings Agent
·
Apr 30

Organon & Co reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 30

Organon Q1 Adj. EPS $0.71 Misses $0.83 Estimate, Sales $1.460B Miss $1.484B Estimate

Benzinga Earnings
·
Apr 30

Organon Q1 revenue and adjusted EPS miss estimates

Reuters
·
Apr 30

Organon Q1 FY26 adjusted net income drops 29% to $188 million; revenue falls 4% to $1.46 billion

Reuters
·
Apr 30

BRIEF-Organon Q1 Adjusted EPS USD 0.71 Vs. IBES Estimate USD 0.83

Reuters
·
Apr 30

Organon Q1 Gross Margin 53.6%

THOMSON REUTERS
·
Apr 30

Organon Q1 Adjusted Ebitda USD 415 Million

THOMSON REUTERS
·
Apr 30